These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 13379555

  • 1. [Renal function in Addison's disease].
    CINOTTI GA, DONATI G, PERICOLI F.
    Prog Med (Napoli); 1956 Sep 30; 12(18):553-9. PubMed ID: 13379555
    [No Abstract] [Full Text] [Related]

  • 2. [Effects of decrease in the effectively circulating blood volume on the renal function in Addison's disease].
    SZABO G, SOLTI F, REV J, MARTON I.
    Magy Belorv Arch (1955); 1957 Feb 30; 10(1):30-2. PubMed ID: 13450562
    [No Abstract] [Full Text] [Related]

  • 3. Effect of reduction of effective circulating blood volume on renal function in Addison's disease.
    SZABO G, SOLTI F, REV J, MARTON I.
    Acta Med Acad Sci Hung; 1957 Feb 30; 10(4):343-7. PubMed ID: 13497560
    [No Abstract] [Full Text] [Related]

  • 4. The significance of renal function for the effect of desoxycorticosterone acetate in Addison's disease.
    LUFT R, SJOGREN B.
    Acta Endocrinol (Copenh); 1949 Feb 30; 2(4):365-78. PubMed ID: 18140397
    [No Abstract] [Full Text] [Related]

  • 5. [Influence of desoxycorticosterone and cortisone on kidney function in Addison's disease].
    BACZYK K, KUHN M, WOJTCZAK A, KOSOWICZ J.
    Pol Arch Med Wewn; 1958 Feb 30; 28(1):1-12. PubMed ID: 13553949
    [No Abstract] [Full Text] [Related]

  • 6. [Renal function in the course of Addison's disease. Influence of the substitute treatment on glomerular filtration and sodium reabsorption].
    ROMANI JD.
    Gaz Med Fr; 1963 Feb 10; 70():457-65. PubMed ID: 13982581
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Addison's disease presenting as loss of weight without pigmentation.
    FELIX-DAVIES D.
    Proc R Soc Med; 1955 Dec 10; 48(12):1023-4. PubMed ID: 13280719
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Adrenal steroid inhibition of vasopressin release from the neurohypophysis of normal subjects and patients with Addison's disease.
    DINGMAN JF, DESPOINTES RH.
    J Clin Invest; 1960 Dec 10; 39(12):1851-63. PubMed ID: 13722985
    [No Abstract] [Full Text] [Related]

  • 14. [Extra-adrenal origin of corticoid hormones. IV. Endocrine and metabolic effects of an ovarian implant in a patient of Addison's disease].
    CASSANO F, CIAMPALINI L, TARANTINO C.
    Folia Endocrinol Mens Incretologia Incretoterapia; 1956 Jun 10; 9(3):315-44. PubMed ID: 13344625
    [No Abstract] [Full Text] [Related]

  • 15. [Kidney function in relation to various adrenocortical dyscrinisms and their medical and surgical treatment].
    BONATI B, BERGAMINI A, RANCATI GB.
    Minerva Med; 1956 May 26; 47(42):1580-7. PubMed ID: 13348269
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The use of intramuscular corticotrophin in examination of adrenal cortex function].
    DE FILIPPIS V, YOUNG II.
    Prog Med (Napoli); 1957 Dec 31; 13(24):812-8. PubMed ID: 13527541
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.